Skip to main content
Back
Watch Compare

Zepp Health Corp

Data quality: 100%
ZEPP
NYSE Technology Consumer Electronics
$13.06
▲ $0.86 (7.05%)
Mkt Cap: 181.93 M
Price
$12.44
Mkt Cap
181.93 M
Day Range
—
52-Week Range
—
Volume
—
Open —
50D / 200D Avg
—
50D / 200D Avg
—

Quick Summary

Key Takeaways

Revenue declined -34.40% annually over 5 years
Debt/Equity of 0.30 — conservative balance sheet
Negative free cash flow of -25.80 M
Revenue growth is decelerating — 1Y growth trails 5Y average by 13.64%
Capital efficient — spends only 0.77% of revenue on capex

Growth

Revenue Growth (5Y)
-34.40%
Below sector avg (7.29%)
Revenue (1Y)-48.04%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
-25.13%
Below sector avg (1.56%)
ROIC-9.18%
Net Margin-41.47%
Op. Margin-25.88%

Safety

Debt / Equity
0.30
Below sector avg (0.42)
Current Ratio1.29
Interest Coverage-8.51

Valuation

PE (TTM)
-2.40
Below sector avg (-0.16)
P/B Ratio0.72
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Technology sector median (1068 peers)
Metric Stock Sector Median
P/E -2.4 -0.2
P/B 0.7 3.0
ROE % -25.1 1.6
Net Margin % -41.5 -0.6
Rev Growth 5Y % -34.4 7.3
D/E 0.3 0.4

Analyst Price Target

1 analyst
Hold
Current
$13.06
+392.9%
Target
$64.37
$64.37
$64.37
$64.37
Forecast
Forward EPS -$0.01
Est. Revenue 0.0

Earnings Estimates

Period EPS Est. Revenue Est. Analysts
FY2027 — 0.0 —
FY2026 -$0.01
-$0.01 – -$0.01
 2.21 B 1

Dividend History

1 yr streak
Ex-Date Payment Date Amount Yield
Mar 25, 2022 — $0.40 N/A

All Fundamental Metrics
Growth
Revenue Growth (1Y) -48.04% Revenue Growth (3Y) -44.86%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) -34.40% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 182.60 M Net Income (TTM) -75.73 M
ROE -25.13% ROA -13.01%
Gross Margin 38.46% Operating Margin -25.88%
Net Margin -41.47% Free Cash Flow (TTM) -25.80 M
ROIC -9.18% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.30 Current Ratio 1.29
Interest Coverage -8.51 Asset Turnover 0.31
Working Capital 56.20 M Tangible Book Value 234.92 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years 1 yrs
Valuation
P/E Ratio -2.40 Forward P/E N/A
P/B Ratio 0.72 P/S Ratio 1.00
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -14.18%
Market Cap 181.93 M Enterprise Value 166.11 M
Per Share
EPS (Diluted TTM) -0.29 Revenue / Share 12.49
FCF / Share -1.76 OCF / Share -1.67
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.77% FCF Conversion 34.06%
SBC-Adj. FCF -30.57 M Growth Momentum -13.64

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 182.60 M 351.46 M 600.66 M 980.78 M 985.96 M
Net Income -75.73 M -29.88 M -41.80 M 21.62 M 35.06 M
EPS (Diluted) -0.29 -0.12 -0.17 0.08 0.13
Gross Profit 70.23 M 92.65 M 116.44 M 204.88 M 204.24 M
Operating Income -47.25 M -29.17 M -59.48 M 14.74 M 26.70 M
EBITDA — — — — —
R&D Expenses 46.16 M 50.96 M 74.98 M 80.83 M 82.45 M
SG&A Expenses — — — — —
D&A 5.02 M 7.67 M 8.50 M 8.14 M 4.16 M
Interest Expense 5.55 M 6.72 M 8.26 M 7.04 M 7.07 M
Income Tax 13.69 M -2.23 M -9.55 M 1.69 M 4.78 M

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 528.59 M 635.52 M 763.74 M 954.95 M 904.79 M
Total Liabilities 275.87 M 282.77 M 374.46 M 494.63 M 486.35 M
Shareholders' Equity 251.59 M 351.07 M 387.48 M 458.27 M 418.43 M
Total Debt 75.24 M 120.02 M 99.20 M 114.06 M 9.20 M
Cash & Equivalents 91.07 M 133.67 M 128.55 M 230.44 M 348.41 M
Current Assets 251.56 M 316.73 M 428.95 M 616.85 M 739.90 M
Current Liabilities 195.37 M 155.11 M 241.93 M 337.72 M 427.54 M